Russell Investments Group
PRAX icon

Russell Investments Group’s Praxis Precision Medicines PRAX Stock Holding History

Russell Investments Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1M Buy
51,033
+27,921
+121% +$8.84M 0.02% 803
2026
Q1 		$7.45M Buy
23,112
+2,500
+12% +$773K 0.01% 1113
2025
Q4 		$6.08M Buy
20,612
+16,208
+368% +$3.02M 0.01% 1193
2025
Q3 		$233K Buy
4,404
+4,155
+1,669% +$201K ﹤0.01% 2759
2025
Q2 		$10.5K Buy
+249
New +$9.48K ﹤0.01% 3327
2025
Q1 		– Sell
-156
Closed -$12K – 3863
2024
Q4 		$12K Sell
156
-1,727
-92% -$125K ﹤0.01% 3103
2024
Q3 		$108K Sell
1,883
-117
-6% -$6.32K ﹤0.01% 2642
2024
Q2 		$82.7K Buy
+2,000
New +$94.5K ﹤0.01% 2664

Other funds holding PRAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Russell Investments Group's PRAX Position: Q2 2026 in Review

Russell Investments Group increased its Praxis Precision Medicines (PRAX) stake by 121% in Q2 2026, buying an estimated $8.84M and bringing the position to 51,033 shares worth $17.1M. The position accounts for 0.02% of the portfolio, ranked #803.

Russell Investments Group first reported a position in PRAX in Q2 2024 and has held it in 8 quarters since. 86 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Russell Investments Group held 51,033 shares of Praxis Precision Medicines worth $17.1M as of Q2 2026.
  • Russell Investments Group bought 27,921 Praxis Precision Medicines shares in Q2 2026, an estimated $8.84M.
  • Praxis Precision Medicines made up 0.02% of Russell Investments Group's portfolio in Q2 2026, its #803 holding.
  • Russell Investments Group first reported a position in Praxis Precision Medicines in Q2 2024 and has held it in 8 quarters since.
  • 86 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.